Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The effects of the selective 5‐HT2 receptor antagonist, ritanserin, on the growth hormone (GH) and prolactin (PRL) responses to intravenous L‐tryptophan (LTP) were assessed in 8 normal volunteers. Administration of ritanserin (40 mg orally) prior to infusion of LTP (5 g) significantly enhanced the PRL responses but not those of GH. The results are consistent with previous proposals that the endocrine responses to LTP are mediated by 5‐HT1 rather than 5‐HT2 receptors and also suggest that 5‐HT2 receptor antagonists may increase certain 5‐HT1 mediated responses in the human brain. Copyright © 1986 John Wiley & Sons, Ltd.

Original publication




Journal article


Human Psychopharmacology: Clinical and Experimental

Publication Date





93 - 97